NCT02856490

Brief Summary

A pilot study to determine the degree and effectiveness of the various modes of vSculpt, an over-the-counter "OTC" medical device, on enhanced genital blood flow and improvement in quality of life in menopausal women who suffer sexual dysfunction and stress incontinence

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 2, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 5, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
4.9 years until next milestone

Results Posted

Study results publicly available

October 26, 2021

Completed
Last Updated

November 24, 2021

Status Verified

August 1, 2016

Enrollment Period

5 months

First QC Date

August 2, 2016

Results QC Date

August 19, 2020

Last Update Submit

October 29, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Blood Flow as Measured by Temperature Change in the Genitalia Using Thermography Technology

    The primary outcomes assessed will be change in blood flow as measured by temperature change in Celsius in the genitalia using thermography technology.

    Pre and post treatment at baseline and pre and post treatment at day 30

Secondary Outcomes (4)

  • Patient Quality of Life as Measured by Female Sexual Function Index (FSFI) Scores at Baseline and 30 Days Post Treatment.

    Baseline and 30 days

  • Patient Quality of Life as Measured by Female Sexual Distress Scores (FSDS) at Baseline and 30 Days Post Treatment.

    Baseline and 30 days

  • Patient Quality of Life as Measured by the Urogenital Distress Inventory, Short Form (UDI-6)

    Baseline and 30 days

  • Patient Quality of Life as Measured by the Incontinence Impact Questionnaire, Short Form (IIQ-7)

    Baseline and 30 days

Study Arms (3)

vSculpt with Vibration Only

ACTIVE COMPARATOR

vSculpt genital device used in vibration mode only.

Device: vSculpt

vSculpt with Vibration and Light

ACTIVE COMPARATOR

vSculpt genital device used in vibration and light mode.

Device: vSculpt

InTone Device

ACTIVE COMPARATOR

InTone genital device using electric muscle stimulation only.

Device: InTone

Interventions

vSculptDEVICE

A genital vibration device that operates in two modes, vibration only or vibration and light, to help tone and tighten pelvic floor muscles.

vSculpt with Vibration OnlyvSculpt with Vibration and Light
InToneDEVICE

A genital device using electric muscle stimulation to treat incontinence.

Also known as: ApexM
InTone Device

Eligibility Criteria

Age48 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Study participants will be female
  • Female participants who are capable of giving informed consent
  • Female participants who are menopausal who have not had a menses within one year, and are within the ages of 48 and 60
  • Female participants who have had one or more vaginal births
  • Female participants who are currently engaged in vaginal sexual intercourse with a partner
  • Female participants who are presently experiencing bladder control issues either leakage, frequency or urgency
  • Female participants who are presently experiencing pain during sexual intercourse

You may not qualify if:

  • Female participants shall not have an active sexually transmitted disease and/or infection
  • Female participants who are actively undergoing chemotherapy
  • Female participants who are currently taking any cancer-related drugs
  • Female participants who are breastfeeding or lactating
  • Female participants who have a medical history of neurological disorders (e.g., multiple sclerosis, Parkinson's disease)
  • Female participants with an active urinary tract infection (UTI)
  • Female participants with active bladder stones
  • Female participants with active bladder tumor(s)
  • Females with prior laser or vaginal rejuvenation surgeries or treatments
  • Females with a medical history of vaginal cancer or radiation or surgery with exception of related to childbirth
  • Females with prior non-invasive treatments (estrogen cream) or pelvic floor physical therapy for the vaginal area/ pelvic floor in the past six month
  • Females with a physical disability precluding her from holding a lithotomy for an hour
  • Females who are homeless

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San Diego Sexual Medicine

San Diego, California, 92120, United States

Location

MeSH Terms

Conditions

Sexual Dysfunction, PhysiologicalUrinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesUrinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Colette Courtion
Organization
Joylux

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 2, 2016

First Posted

August 5, 2016

Study Start

July 1, 2016

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

November 24, 2021

Results First Posted

October 26, 2021

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share

Locations